MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson's disease

Saraiva, C., Paiva, J., Santos, T., Ferreira, L., Bernardino, L.·2016·Journal of Controlled Release

Cited by (169)

Items 101–169 of 169

  1. MicroRNAs Dysregulation and Metabolism in Multiple System Atrophy
    Chunchen Xiang, Shunchang Han, Jianfei Nao, Shuyan Cong · 2019 · Frontiers in Neuroscience
  2. Particulate systems for improving therapeutic efficacy of pharmaceuticals against central nervous system-related diseases
    Yung‐Chih Kuo, Rajendiran Rajesh · 2020 · Journal of the Taiwan Institute of Chemical Engineers
  3. Let's get small (and smaller): Combining zebrafish and nanomedicine to advance neuroregenerative therapeutics
    David T. White, Meera T. Saxena, Jeff S. Mumm · 2019 · Advanced Drug Delivery Reviews
  4. MiR‐9‐5p Inhibits the MMP+‐Induced Neuron Apoptosis through Regulating SCRIB/β‐Catenin Signaling in Parkinson’s Disease
    Zhenyong Xiao, Zhenxing Yan, Xiang Sun, Zhiyuan Zhu, Baoyan Wang, Mengqi Gao, Fengfei Lu, Jian Liu, Zhitao Zong, Hongbo Zhang et al. · 2022 · Oxidative Medicine and Cellular Longevity
  5. Application of Gray Level co-Occurrence Matrix Algorithm for Detection of Discrete Structural Changes in Cell Nuclei After Exposure to Iron Oxide Nanoparticles and 6-Hydroxydopamine
    Dubravka Nikolovski, Jelena Cumic, Igor V. Pantic · 2019 · Microscopy and Microanalysis
  6. Engineering microglial exosome-mediated microRNA-124-3p delivery for Alzheimer's disease combinational therapy
    Jia Ke, Jing Ding, Yichong Xu, Caini Yu, Yiling Hong, Sufen Li, Tingting Meng, Ping Yuan, Hong Yuan, Fuqiang Hu · 2025 · Biomaterials Science
  7. Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases
    Ammara Saleem, Maira Javed, Muhammad Furqan Akhtar, Ali Sharif, Bushra Akhtar, Muhammad Naveed, Uzma Saleem, Mirza Muhammad Faran Ashraf Baig, Hafiz Muhammad Zubair, Talha Bin Emran et al. · 2023 · Current Gene Therapy
  8. Modulation of β secretase and neuroinflammation by biomimetic nanodelivery system for Alzheimer's disease therapy
    Xiaolei Song, Chenchen Wang, Qin Ding, Peng Li, Shihao Sun, Wei Wei, Juan Zhang, Rongli Sun, Lihong Yin, Songqin Liu et al. · 2024 · Journal of Controlled Release
  9. A Glance at Biogenesis and Functionality of MicroRNAs and Their Role in the Neuropathogenesis of Parkinson’s Disease
    Adam Szelągowski, Mariusz Kozakiewicz · 2023 · Oxidative Medicine and Cellular Longevity
  10. The Effect of Melatonin Modulation of Non-coding RNAs on Central Nervous System Disorders: An Updated Review
    Jianan Lü, Yujie Luo, Shuhao Mei, Yuanjian Fang, Jianmin Zhang, Sheng Chen · 2020 · Current Neuropharmacology
  11. MicroRNAs in Parkinson’s disease: From pathogenesis to diagnostics and therapeutic strategies
    Dongying Zheng, Jibing Chen · 2025 · Neuroscience
  12. Different classes of small RNAs are essential for head regeneration in the planarian Dugesia japonica
    Zhonghong Cao, David Rosenkranz, Suge Wu, Hongjin Liu, Qiuxiang Pang, Xiufang Zhang, Baohua Liu, Bosheng Zhao · 2020 · BMC Genomics
  13. RNA therapeutics for neurological diseases
    Ilaria Brentari, Mariia Zadorozhna, Michela A. Denti, Elisa Giorgio · 2023 · British Medical Bulletin
  14. Polymeric nanotherapeutics: An emerging therapeutic approach for the management of neurodegenerative disorders
    Pratik Chakraborty, Chiranjib Bhattacharyya, Ranabir Sahu, Tarun Kumar Dua, Ramesh J. L. Kandimalla, Saikat Dewanjee · 2023 · Journal of Drug Delivery Science and Technology
  15. New Insights on the Potential Role of Pyroptosis in Parkinson’s Neuropathology and Therapeutic Targeting of NLRP3 Inflammasome with Recent Advances in Nanoparticle-Based miRNA Therapeutics
    ‏Hebatallah M. Saad, Esraa A. Salem, Abeer E. Elsayed · 2025 · Molecular Neurobiology
  16. Propofol Exposure Disturbs the Differentiation of Rodent Neural Stem Cells via an miR-124-3p/Sp1/Cdkn1b Axis
    Jun Cao, Yan Li, Fanning Zeng, Xiaolei Liu, Tao Tao, Zaisheng Qin · 2020 · Frontiers in Cell and Developmental Biology
  17. Engineering graphene-based electrodes for optical neural stimulation
    Artur Filipe Rodrigues, Ana P. M. Tavares, Susana M. N. Simões, Rui P. F. F. Silva, Tomás Sobrino, Bruno R. Figueiredo, M. Goreti F. Sales, Lino Ferreira · 2022 · Nanoscale
  18. Olfactory bulb neurogenesis depending on signaling in the subventricular zone
    Yali Chen, Peng Ren, Xiongjie He, Yan Fang, Rou Gu, Jie Bai, Xianwen Zhang · 2023 · Cerebral Cortex
  19. Therapeutic and Toxicological Aspects of Some Metal Nanoparticles on The Central Nervous System: A Review
    Fady Sayed Youssef, Omar A. Fouad, Sameh Hamed Ismail, Gehad Genidy Mohamed · 2023 · Egyptian Journal of Veterinary Science
  20. Microcystin-LR-Triggered Neuronal Toxicity in Whitefish Does Not Involve MiR124-3p
    Maciej Florczyk, Paweł Brzuzan, Alicja Łakomiak, EWA JAKIMIUK, Maciej Woźny · 2018 · Neurotoxicity Research
  21. Exosomal microRNAs as diagnostic biomarkers and therapeutic applications in neurodegenerative diseases
    Xuehereti Sataer, Zhu Qifeng, Zhang Yingying, He Chunhua, Feng Bingzheng, Zhi‐Ran Xu, Li Wanli, Yang Yuwei, Chen Shuangfeng, Lingling Wu et al. · 2022 · Neurological Research
  22. MicroRNA-124-3p Modulates Alpha-Synuclein Expression Levels in a Paraquat-Induced in vivo Model for Parkinson’s Disease
    Marta Esteves, Ana Clara Cristóvão, Ana Margarida Vale, Marta Machado‐Pereira, Raquel Ferreira, Liliana Inácio Bernardino · 2024 · Neurochemical Research
  23. Multiomics analysis identifies novel facilitators of human dopaminergic neuron differentiation
    Borja Gomez Ramos, Jochen Ohnmacht, Nikola de Lange, Elena Valceschini, Aurélien Ginolhac, Marie Catillon, Daniele Ferrante, Aleksandar Raković, Rashi Halder, François Massart et al. · 2023 · EMBO Reports
  24. Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders
    Austin Lui, Timothy Do, Omar Alzayat, Nina Yu, Su Myat Phyu, Hillary Joy Santuya, Benjamin Liang, Vidur Kailash, Dewey Liu, Sabra S. Inslicht et al. · 2024 · Pharmaceuticals
  25. Identification of differentially expressed microRNAs and their target genes in the hippocampal tissues of Fmr1 knockout mice.
    Malan Zhang, Xin Li, Xiao Du, Tao Lu, Bing Qin, Zhigang Zheng, Yonggen Zhang, Yi Liu, Tiebin Yan, Xinjia Han · 2020 · PubMed Central
  26. A Comprehensive Study of miRNAs in Parkinson’s Disease: Diagnostics and Therapeutic Approaches
    Yasir Hasan Siddique, Saima Owais · 2022 · CNS & Neurological Disorders - Drug Targets
  27. Unraveling the Ties: Type 2 Diabetes and Parkinson's Disease - A Nano-Based Targeted Drug Delivery Approach
    Sourav De, Sabyasachi Banerjee, Pallabita Rakshit, Subhasis Banerjee, S.K. Ashok Kumar · 2024 · Current Diabetes Reviews
  28. CtBP Neuroprotective Role in Toxin-Based Parkinson’s Disease Models: From Expression Pattern to Dopaminergic Survival
    Cláudia Saraiva, Jéssica Lopes‐Nunes, Marta Esteves, Tiago Santos, Ana Margarida Vale, Ana Clara Cristóvão, Raquel Ferreira, Liliana Inácio Bernardino · 2023 · Molecular Neurobiology
  29. Neurotoxic Effects of Nanoparticles and their Pathogenesis
    Sunena, Deepali Tomar, Sunil Jawla · 2023 · Pharmaceutical Nanotechnology
  30. Nanoengineered biomaterials for neurodegenerative disorders
    Satheeswaran Balasubramanian, Azhwar Raghunath, Ekambaram Perumal · 2020 · Elsevier eBooks
  31. Impact of Nanotechnology on the Realm of Stem Cells and Regenerative Medicine
    Saumya Dash, Adeeba Shakeel, Sujata Mohanty · 2022 · ChemNanoMat
  32. Targeting the pathogenesis and boosting the therapeutic efficacy of Parkinson's disease by advanced nanoparticles
    Hanghang Liu, Menglong Hua, Qing Yin Zheng, Yifan Gao, Zhen Li · 2023 · MedComm – Biomaterials and Applications
  33. Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease
    Sourav De, Yung‐Chih Kuo · 2024 · Journal of the Taiwan Institute of Chemical Engineers
  34. Stereotaxic-assisted gene therapy in Alzheimer’s and Parkinson’s diseases: therapeutic potentials and clinical frontiers
    Samar O. El-Ganainy, Tony Cijsouw, Mennatallah A. Ali, Susanne Schoch, Amira Sayed Hanafy · 2022 · Expert Review of Neurotherapeutics
  35. Nanobiotechnology in Parkinson’s Disease
    Pablo Vicente Torres-Ortega, Iván Martínez-Valbuena, Gloria Martí‐Andrés, Amira Sayed Hanafy, María Rosario Luquin, Elisa Garbayo, María J. Blanco‐Prieto · 2019 · Springer eBooks
  36. Evaluation role of miR-124 in neurodegenerative diseases: literature review and in silico analysis
    Javad Amini, Bahram Bibak, Amir R Afshar, Amirhossein Sahebkar · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Nanomedicines for the treatment of ischemic stroke: An overview of recent advances
    Siqi Geng, Caiyun Zhang, João Rodrigues, Dzmitry Shcharbin, Serge M. Mignani, Jean‐Pierre Majoral, Mingwu Shen, Xiangyang Shi · 2025 · Precision medicine and engineering.
  38. MicroRNA-132 regulates quinolinic acid production in the brain during LPS-induced neuroinflammation
    Amir Mohamed Kezai, Papa Yaya Badiane, Benjamin Hennart, Delphine Allorge, Sabrina Marion, Sébastien S. Hébert · 2025 · Frontiers in Immunology
  39. Unveiling Exosomes and Microvesicles in Parkinson’s Disease: Mechanistic Insights Into Cell Death Pathways and Therapeutic Potential
    Waleed K. Abdulsahib, Wael Waleed Mustafa, S. Renuka Jyothi, Priya Priyadarshini Nayak, J Bethanney Janney, Gurjant Singh, Aashna Sinha, Reza Akhavan‐Sigari · 2025 · Molecular Neurobiology
  40. Nanoengineering and nanotechnology for diagnosis and treatment of CNS and neurological diseases
    Pramod Kumar, Aradhana Dwivedi, Kitiporn Plaimas, Kalpana Sagar, Lakshita Chauhan · 2023 · Elsevier eBooks
  41. Polymeric nanosystems for neurological therapeutics
    Naumih M. Noah, Peter Munyao Ndangili · 2023 · Elsevier eBooks
  42. MicroRNA-124 conducts neuroprotective effect via inhibiting AK4/ATF3 after subarachnoid hemorrhage
    Wei Jiang, Qingge Jia, Hongxin Ma, Song Hyun Han, Shijun Bi, Kunyuan Zhu, Ligang Chen, Guobiao Liang · 2023 · Experimental Brain Research
  43. Challenges of Using Nanotechnology for Neurological Disorders and Alternate Solutions
    Swarnali Das, Rubai Ahmed, Sovan Samanta, Jhimli Banerjee, Sandeep Kumar Dash · 2023 · Springer eBooks
  44. Investigating nanoparticle’s utilization in stem cell therapy for neurological disorders
    Sadia Aziz · 2025 · American Journal of Stem Cells
  45. MicroRNAs in neurodegenerative diseases: from molecular mechanisms to clinical biomarkers, detection methods and therapeutic strategies—advances and challenges
    Hafiz Muhammad Husnain Azam, Mehvish Mumtaz, Stefan Rödiger, Peter Schierack, Nazim Hussain, Aisha Ambreen · 2025 · Neurological Sciences
  46. The Dynamic Roles of Repressor Element 1-Silencing Transcription Factor (REST): A Double-Edged Sword in Neural Health and Disease
    Taslima Akter Eva, Avinash Shenoy, Veer Bala Gupta, Viswanthram Palanivel, Akanksha Salkar, Sohrab Nowroozi Nasab, Nitin Chitranshi, Mehdi Mirzaei, Yuyi You, Stuart L. Graham et al. · 2025 · Molecular Neurobiology
  47. MiR-124 involvement of apoptosis, immunity and regulator of diseases
    Sun HongYan, Huang You-Hua, Yu Zong-He, Qin Qi-Wei · 2020 · AFRICAN JOURNAL OF BIOTECHNOLOGY
  48. Pathophysiology and Management Approaches for Parkinson’s Disease
    Sabiya Samim Khan, Padmashri Naren, Poojitha Pinjala, Sai Nikhil Uppala, Shashi Bala Singh, Dharmendra Kumar Khatri · 2023 · Springer eBooks
  49. Neural Stem Cell-Based Therapeutic Approaches for Brain Repair
    Cláudia Saraiva, Tiago Santos, Liliana Inácio Bernardino · 2018 · Springer eBooks
  50. Drug delivery systems for engineering neural tissue
    Stephanie Michelle Willerth · 2017 · Elsevier eBooks
  51. Bone Marrow Mesenchymal Stem Cells' Secretome Exerts Neuroprotective Effects in a Parkinson's Disease Rat Model
    Bárbara Filipa Mendes Pinheiro, Sandra Isabel Anjo, Bruno J. Manadas, Jorge Diogo Da Silva, Ana Marote, Leo A. Behie, Fábio Gabriel Teixeira, António José Salgado · 2019 · SSRN Electronic Journal
  52. Exosomes: Future Perspective in Neurodegenerative Diseases
    Leila Alidoust, Adele Jafari · 2020 · Caspian Journal of Neurological Sciences
  53. The implication of lncRNAs in the regulation of inflammation
    Izei Pascual-González, Henar Rojas Márquez · 2025 · Advances in genetics
  54. Therapeutic Approaches for Stroke: A Biomaterials Perspective
    Artur Filipe Rodrigues, Catarina Rebelo, Tiago Reis, João André Sousa, Sónia L. C. Pinho, João Sargento‐Freitas, João Peça, Lino Ferreira · 2021 · Springer eBooks
  55. Neural regenerative nanomedicine: current therapies and future direction
    Fatemeh Khatami · 2020 · Elsevier eBooks
  56. Multi-omics analysis identifies LBX1 and NHLH1 as central regulators of human midbrain dopaminergic neuron differentiation
    Borja Gomez Ramos, Jochen Ohnmacht, Nikola de Lange, Aurélien Ginolhac, Elena Valceschini, Aleksandar Raković, Rashi Halder, François Massart, Christine Klein, Roland Krause et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  57. Nanoparticles Treat Ischemic Stroke by Responding to Stroke Microenvironment
    Defeng Cao, Wenya Chen, Aijin Ma, Manyun Cheng, Bona Wu · 2023 · BioNanoScience
  58. Potential role of exosomal miRNA in disease progression and therapeutics
    Abhishek Bhattacherjee · 2024 · Elsevier eBooks
  59. Brain Health and Nano Medicine
    Tuba Tarhan · 2024
  60. Synthesis and Comprehensive Characterization of Neurocompatible Biomaterials
    Ira Singh, Santosh Kumar · 2025 · Springer eBooks
  61. Advanced gene therapy in Parkinson’s disease through innovations in drug delivery systems
    Phuong-Anh Tran Nguyen, Thuy-vi Nguyen, Soyeun Park · 2025 · Journal of Pharmaceutical Investigation
  62. Role of Sulforaphane in Neurodegenerative Diseases: A Focus on Parkinson’s Disease
    MD Naushad Ali, Radha Goel, Rajeev Kumar · 2025 · International Journal of Newgen Research in Pharmacy & Healthcare
  63. Mechanisms of Autophagy and Its Dysregulation in Neurodegenerative Diseases
    Saroj Singhmura, Sagarika Deepthy Tallapragada, Atreyee Ganguly, Jashabir Chakraborty, Abhishek Basu, Yadu Nandan Dey · 2025 · Springer eBooks
  64. Insights From a Scoping Review and Bibliometric Analysis of Trends and Advances in Biomarker Research: The Role of MicroRNAs in Cognitive Decline Across Neurodegenerative Diseases
    Samuel Reyes-Long, Ernesto Roldán-Valadéz, José Luis Cortes-Altamirano, Denise Clavijo‐Cornejo, Alfonso Alfaro-Rodríguez · 2025 · Cureus
  65. Additional file 1 of Different classes of small RNAs are essential for head regeneration in the planarian Dugesia japonica
    Cao, Zhonghong, David Rosenkranz, Suge Wu, Liu, Hongjin, Pang, Qiuxiang, Zhang, Xiufang, Liu, Baohua, Bosheng Zhao · 2021 · Figshare
  66. Bridging Regenerative and Restorative Stem Cell Therapies in Parkinson’s Disease
    Chiamaka C Onuigbo, Juan Diego Martínez-Lemus, Emily Tharp, Mya Caryn Schiess · 2026 · Cells
  67. Nanotechnology-driven therapeutic strategies for lambert–eaton myasthenic syndrome: Emerging drug delivery and immunomodulatory approaches
    T. Jaghatha, Justus Oliver Jaslin Edward, Somasundaram Arumugam, Pavazhaviji Pazhani, Jose Prakash Dharmian · 2026 · Next Nanotechnology
  68. Antibiotics and nanoparticles in Parkinson’s disease: From gut microbiota dysbiosis to neuroprotection and targeted nanotherapies
    Marie Rose Frangieh, Martine Saad, Nour Fattouh, Simona Sawan · 2026 · Biomedicine & Pharmacotherapy
  69. MiR‑204‑5p modulates glial morphology and apomorphine‑induced rotational asymmetry without dopaminergic neuroprotection in a preclinical mouse model of Parkinson’s disease
    Catarina Serra-Almeida, Ana Vale, Inês Tomé-Ribeiro, Marta Barão, Ana Clara Cristóvão, Lino Ferreira, Liliana Bernardino · 2026 · Metabolic Brain Disease